Press release

Neuronfab Established: A Game-Changer in Neuroscience Innovation

Cologne, April 2024 – Neuronfab is thrilled to announce its official legal foundation in April 2024, marking the beginning of a bold new chapter in neuroscience innovation. The company is on a mission to transform how brain-related diseases are studied and treated by introducing cutting-edge human brain organoids to the market.

 

Neuronfab Changes the Paradigm

Traditional methods of studying the human brain often rely on animal models, which fail to capture the full complexity and unique biology of the human brain. Neuronfab is redefining this approach with human brain organoids that are physiologically relevant and scalable, enabling researchers to decode disease mechanisms and develop novel therapeutic targets and drugs.

“We are here to change the way neuroscience is done,” said Valeria Küpper, CEO. “With our innovative and patent-protected production methods, we are offering solutions that not only advance scientific discovery but also provide hope for patients who currently have no effective treatments.”

 

Our Solutions

Neuronfab’s groundbreaking platform is built around its patent-protected technology for the scalable production of cryopreserveable human brain organoids. These organoids stand out due to:

• Unmatched Homogeneity and Cell Variety: Perfectly mimic the unique physiology of the human brain.

• Cryopreservability and Reculturability: Ready for shipment worldwide, ensuring accessibility to researchers everywhere.

• High-Quality Applications: Ideal for pre-clinical research, therapeutic target development, and drug discovery.

By supplying industries with human brain organoids and related services, Neuronfab is setting a new standard in neuroscience research and pre-clinical applications.

 

Hope for Patients and a Better Future

Neuronfab’s solutions not only offer greater effectiveness and efficiency in drug development but also align with ethical imperatives by reducing reliance on animal testing. “Our human brain organoids are a game-changer for neuroscience, offering researchers the tools to explore the complexities of the human brain with unprecedented accuracy,” added Dr. Elke Gabriel, CSO.

 

About Neuronfab

Neuronfab was founded with the mission of advancing neuroscience through innovative human brain organoid solutions. Our robust and scalable methods provide researchers and industries with tools to explore the complexities of the human brain, ultimately paving the way for groundbreaking treatments and discoveries.

 

For media inquiries, please contact:
contact@neuronfab.com